Results 1 to 10 of about 23,012 (218)

Decade-long protection of the mumps vaccine: Insights from a large-scale serological study. [PDF]

PLoS Neglected Tropical Diseases
BackgroundSerological surveys of mumps are important for estimating susceptibility in the population and for evaluating the effectiveness of current vaccination strategies.MethodsA cross-sectional serological survey using an enzyme-linked immunosorbent ...
Zixia Qian, Yueling Chen, Lilian Zeng, Chumin Liang, Weizhao Lin, Can Xiong, Xinxin Li, Yingyin Deng, Liang Chen, Ying Yang, Limei Sun, Jianfeng He, Jiufeng Sun   +12 more
doaj   +3 more sources

Factors associated between behavior of administrating or recommending mumps vaccine and primary care physicians’ knowledge about vaccination: A nationwide cross‐sectional study in Japan [PDF]

Journal of General and Family Medicine, 2022
Background In Japan, the mumps‐containing vaccine was withdrawn from routine vaccination in 1993, and it became a voluntary vaccination. This study aimed to evaluate the association between the physicians’ knowledge about vaccinations and the ...
Jiro Takeuchi, Yuta Sakanishi, Tadao Okada, Kuniko Nakayama, Hiroshi Chiba, Rei Suganaga, Yosuke Nishioka, Tomomi Kishi, Tomio Suzuki, Preventive Medicine, Health Promotion Committee Vaccine Team, Japan Primary Care Association, Japan   +9 more
doaj   +2 more sources

Improved Immunogenicity of the Inactivated F Genotype Mumps Vaccine against Diverse Circulating Mumps Viruses in Mice [PDF]

Vaccines, 2023
Mumps is an acute infectious disease caused by the mumps virus (MuV). Despite high global vaccination coverage, mumps outbreaks continue to occur, even in vaccinated populations.
Hyeran Won, Ah-Ra Kim, Gyung Tae Chung, Su Hwan Kim, Jung-Sik Yoo, June-Woo Lee   +5 more
doaj   +2 more sources

Mumps vaccine effectiveness of a 3rd dose of measles, mumps, rubella vaccine in school settings during a mumps outbreak -- Arkansas, 2016-2017 [PDF]

Public Health in Practice, 2023
Objectives: The largest mumps outbreak in the United States since 2006 occurred in Arkansas during the 2016-17 school year. An additional dose (third dose) of measles-mumps-rubella vaccine (MMR3) was offered to school children.
Angela Guo, Jessica Leung, Tracy Ayers, Virgie S. Fields, Haytham Safi, Catherine Waters, Aaron T. Curns, Janell A. Routh, Dirk T. Haselow, Mariel A. Marlow, Mona Marin   +10 more
doaj   +2 more sources

Booster doses of an inactivated F genotype mumps vaccine enhance immunogenicity in mice [PDF]

Vaccine: X
The mumps virus (MuV) causes a highly contagious human disease characterized by swelling of the parotid glands. Although the administration of an attenuated Jeryl Lynn (JL) MuV vaccine shows efficacy in reducing the incidence of MuV infection, sporadic ...
Seo Yeon Kim, Tae-Young Lee, Yun-Ho Hwang, Dokeun Kim, You-Jin Kim, Hyeran Won   +5 more
doaj   +2 more sources

Development and Biological Properties of a New Live Attenuated Mumps Vaccine Strain [PDF]

Vaccines
Background/Objectives: This study aimed to develop a new attenuated live mumps vaccine strain and determine its biological properties and effectiveness. Methods: Plaque purification and amplification were performed in chicken embryo cells. Candidate live
Xue Song, Xiumei Ren, Yang Song, Shengbao Yang, Kailang Lu, Yan Zhang, Jiankai Liu   +6 more
doaj   +2 more sources

Antibody Levels at 3-Years Follow-Up of a Third Dose of Measles-Mumps-Rubella Vaccine in Young Adults [PDF]

Vaccines, 2022
Mumps outbreaks and breakthrough infections of measles and rubella have raised concerns about waning of vaccine-induced immunity after two doses of measles-mumps-rubella (MMR) vaccination.
Patricia Kaaijk, Alienke J. Wijmenga-Monsuur, Hinke I. ten Hulscher, Jeroen Kerkhof, Gaby Smits, Mioara Alina Nicolaie, Marianne A. van Houten, Rob S. van Binnendijk   +7 more
doaj   +2 more sources

Vaccine coverage, antibodies against measles, mumps, rubella, hepatitis B in inflammatory bowel disease and juvenile idiopathic arthritis children. [PDF]

World J Clin Pediatr
Makarova E, Goleva O, Gabrusskaya T, Lubimova N, Ulanova N, Volkova N, Shilova E, Revnova M, Kharit S, Kostik M.   +9 more
europepmc   +2 more sources

Determination of ELISA reactive mumps IgG antibodies in MMR vaccine recipients in comparison with MMR vaccine naive children: A cross sectional study [PDF]

Scripta Medica, 2021
Background/Aim: Mumps is by vaccine preventable infectious disease characterised by parotitis. In India mumps vaccines are not currently used under National Immunisation Programme (NIP).
Gupta Riya, Saxena Naveen, Gupta Parul
doaj   +1 more source

Risk factors for mumps in children under 15 years of age during the transition from single-dose to two-dose MMR vaccination strategy: a matched case-control study [PDF]

Frontiers in Public Health
BackgroundThis study aimed to investigate the risk factors for mumps in children under 15 years of age during the transition from a single-dose to a two-dose measles–mumps–rubella (MMR) vaccine strategy, providing a scientific basis for public health ...
Huaxian Liu, Yan Xie, Zhongkui Zhu, Yuanbao Liu, Yang Yu, Jintao Wang, Lu Shen, Yunke Qian, Wanqin Tang   +8 more
doaj   +2 more sources